ECILC vs SMRVA Comparison
Price, market cap, valuation, profitability and leverage metrics of ECILC and SMRVA side by side.
If You Had Invested TRY 10,000
Metric Comparison
| Metric | ECILC | SMRVA | Sector median |
|---|---|---|---|
| Last price (TL) | 64.00 | 7.13 | 18.72 |
| Daily change | −6.57% | −3.65% | −5.97% |
| Market cap | TRY 43.9B | TRY 4.3B | TRY 4.3B |
| P/E | — | 7.70 | 17.25 |
| P/B | 0.68 | 1.72 | 1.08 |
| Dividend yield | 2.04% | 1.21% | 0.90% |
| Return on equity | −3.08% | 22.77% | 1.78% |
| Free float | 22.02% | 26.61% | 37.21% |
Popular Comparisons
Related Pages
About the ECILC vs SMRVA Comparison
Price, market cap, valuation multiples, profitability and leverage of ECILC (Eczacıbaşı İlaç) and SMRVA (Sumer Varlik Yönetim) side by side as of Sep 28, 2026, 15:51. Of the 7 metrics compared, ECILC leads in 3 and SMRVA leads in 4.
Highlights: Daily change: SMRVA leads (−3.65% vs −6.57%). Market cap: ECILC leads (TRY 43.9B vs TRY 4.3B). P/B: ECILC leads (0.68 vs 1.72). Dividend yield: ECILC leads (2.04% vs 1.21%). Net margin (annual): SMRVA leads (4.88% vs −20.86%). Return on assets: SMRVA leads (10.99% vs −2.50%). Return on equity: SMRVA leads (22.77% vs −3.08%).
Frequently Asked Questions
Is ECILC or SMRVA cheaper?
By P/E, Tie is cheaper (— vs 7.70); by P/B, ECILC trades at the lower multiple (0.68 vs 1.72).
Which is more profitable, ECILC or SMRVA?
Annual net margin is −20.86% for ECILC and 4.88% for SMRVA; return on equity is −3.08% for ECILC and 22.77% for SMRVA.
Which is more leveraged, ECILC or SMRVA?
The leverage ratio is 18.92 for ECILC and — for SMRVA; net debt/EBITDA is 1.37 for ECILC and — for SMRVA. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.